Memantine LEK
Երկիր: Եվրոպական Միություն
Լեզու: լեհերեն
Աղբյուրը: EMA (European Medicines Agency)
Տեղեկատվական թերթիկ
(PIL)
16-11-2020
Ապրանքի հատկությունները
(SPC)
16-11-2020
Հանրային գնահատման հաշվետվություն
(PAR)
29-04-2013
Ակտիվ բաղադրիչ:
chlorowodorek memantyny
Հասանելի է:
Pharmathen S.A.
ATC կոդը:
N06DX01
INN (Միջազգային անվանումը):
memantine
Թերապեւտիկ խումբ:
Psychoanaleptics i inne anty-demencji leki
Թերապեւտիկ տարածք:
Choroba Alzheimera
Թերապեւտիկ ցուցումներ:
Leczenie pacjentów z umiarkowaną lub ciężką chorobą Alzheimera.
Ապրանքի ամփոփագիր:
Revision: 5
Լիազորման կարգավիճակը:
Upoważniony
Հաստատման ամսաթիվը:
2013-04-21
Տեղեկատվական թերթիկ
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Կարդացեք ամբողջական փաստաթուղթը
Ապրանքի հատկությունները
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Կարդացեք ամբողջական փաստաթուղթը
